A Study of Tirzepatide in Overweight and Very Overweight Participants
A Study to Measure Food and Calorie Consumption in Very Overweight Participants Using Tirzepatide
A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS
A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19) (BLAZE-5)
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes.
A Study of LY3471851 in Participants With Eczema
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere)
A Study of LY3561774 in Participants With Dyslipidemia.
A Study of LY3462817 in Participants With Rheumatoid Arthritis
A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer
A Study of LY3502970 in Participants With Type 2 Diabetes
A Study of LY3451838 in Participants With Migraine
A Study of Mealtime Insulin LY900014 in Participants with Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range)
A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
A Study of LY3372993 in Participants With Alzheimer's Disease (AD)
A Study of Baricitinib (LY3009104) in Participants With COVID-19 (COV-BARRIER)
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)
A Study of Baricitinib in Participants With Rheumatoid Arthritis
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer ( EMBER )
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
A Study of LY3041658 in Adults With Hidradenitis Suppurativa
Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer (CYCLONE 1)
A Study of Donanemab (LY3002813) in Participants with Early Alzheimer’s Disease (TRAILBLAZER-ALZ 2)
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA
A Study of Abemaciclib (LY2835219) in Combination With Temozolomide and Irinotecan and Abemaciclib in Combination With Temozolomide in Children and Young Adult Participants With Solid Tumors
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness (BLAZE-1)
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program (SURMOUNT-3)
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants with Osteoarthritis
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss (SURMOUNT-4)
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Chronic Low Back Pain
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis (LUCENT-ACT)
A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (EMBER-2)
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) (LIBRETTO-432)
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer (eMonarcHER)
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
A Study of LY2951742 in the Prevention of Chronic Migraine (REGAIN)
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis (Eczema) (BREEZE-AD3)
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (REACH-2)
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer (JUNIPER)
A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis (COAST-Y)
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis (Eczema) Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable (BREEZE-AD4)
A Study to Compare Treatment After Surgery of Abemaciclib (LY2835219) Combined With Standard Endocrine Therapy Versus Endocrine Therapy Alone in Participants With Breast Cancer (monarchE)
A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (ANNOUNCE-2)
A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
A Study of Solanezumab in Older Participants Who May be at Risk for Memory Loss (A4)
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis (Eczema) (BREEZE-AD5)
A Study of LY3200882 in Participants With Solid Tumors
A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors (PACT)
A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (Hair Loss)
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (nextMONARCH 1)
A Study of LY3023414 in Participants With Advanced Cancer
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer (monarcHER)
A Study of Abemaciclib (LY2835219) in Combination With Other Therapies in Participants With Breast Cancer That Has Spread
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
A Study of LY3471851 in Participants With Psoriasis
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
A Safety Study of LY3462817 in Participants With Psoriasis
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Participants With EGFR Mutation-Positive Metastatic NSCLC
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes (AWARD-PEDS)
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC or Transitional Cell Carcinoma of the Urothelium
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
A Study of LY3209590 in Participants With Type 1 Diabetes
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff (BLAZE-2)
A Study of LY3154207 in Participants With Parkinson's Disease (Part B)
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis (COAST-W)
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, Hepatocellular Carcinoma, or Glioblastoma
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis (IXORA-Q)
A Study of LY3041658 in Participants With Skin Diseases
A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
A Study of LY3303560 in Participants with Mild Cognitive Impairment or Alzheimer's Disease
A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD
A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis (Eczema) (BREEZE-AD2)
A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)
A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
A Study of LY2951742 in the Prevention of Episodic Migraine (EVOLVE-2)
A Study of LY900014 in a Medtronic Pump
A Study Comparing LY900014 to Insulin Lispro in Adults With Type 1 Diabetes Using Insulin Pump Therapy
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
A Study of LY2951742 in the Prevention of Episodic Migraine (EVOLVE-1)
A Study of LY2157299 in Participants With Hepatocellular Carcinoma
A Study of Lasmiditan in Participants With Migraine
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma
A Study of LY2875358 in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes (PRONTO-Pump)
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
A Safety Study of LY2951742 in Participants With Migraine, With or Without Aura
A Study of LY2510924 and Durvalumab in Participants With Solid Tumors
A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis
A Study of Ixekizumab in Participants with Plaque Psoriasis
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis (IXORA-P)
A Study of LY2606368 in Participants With Advanced Cancer
A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
A Study of Mirikizumab in Participants With Plaque Psoriasis
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis (IXORA-S)
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer
A Study of LY3023414 and Necitumumab in Participants With Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis (COAST-X)
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis (COAST-V)
A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)
A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)
A Study of Necitumumab (LY3012211) and Abemaciclib (LY2835219) in Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
A Study of LY3039478 in Participants with Advanced Cancer
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies
A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
A Study of Abemaciclib (LY2835219) Alone or in Combination with Other Agents in Participants with Previously Treated Pancreatic Ductal Adenocarcinoma
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (AWARD-11)
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body
A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19
A Study of LY3127804 with Ramucirumab in Participants with Advanced Solid Tumors
A Study of LY2951742 in Participants With Episodic Cluster Headache
A Study of LY2801653 in Participants With Advanced Cancer
A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants with Type 2 Diabetes Mellitus (VIVID)
A Study of LY2951742 in Participants With Chronic Cluster Headache
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
A Study of Tirzepatide in Participants With Impaired Liver Function
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated with Idiopathic Parkinson’s Disease (PD) or Dementia with Lewy Bodies (DLB) (PRESENCE)
A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis
A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Study of Enzalutamide and LY3023414 in Men with Prostate Cancer
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer (neoMONARCH)
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC
A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis (SPIRIT P3)
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
A Study of LY3209590 in Participants With Type 2 Diabetes
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus (Award-10)
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis (Spirit-H2H)
A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis (Eczema) (BREEZE-AD1)
A Study of LY3202328 in Overweight Healthy Participants and in Participants With Dyslipidemia
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma that has Spread to the Brain
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body
A Study of LY3022855 In Participants With Breast or Prostate Cancer
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes (T2DM)
A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
A Study of LY3361237 in Participants With Systemic Lupus Erythematosus
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
A Study of Galcanezumab (LY2951742) in Participants with Cluster Headache
A Study of LY3405105 in Participants With Advanced Cancer
A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a CGRP Antagonist
A Study of LY3493269 in Participants With Type 2 Diabetes
A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease (SERENITY)
A Study of Prexasertib (LY2606368) with Chemotherapy and Radiation in Participants with Head and Neck Cancer
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
A Study of LY3337641 in Participants With Rheumatoid Arthritis (RAjuvenate)
A Study of Lanabecestat (LY3314814) in Participants With Early Alzheimer's Disease Dementia
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Participants With Early Alzheimer's Disease (AMARANTH)
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia (NAVIGATE-AD)
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)
A Study of LY3415244 in Participants With Advanced Solid Tumors
A Study of LY2599666 in Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
A Study of LY3435151 in Participants With Solid Tumors
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
A Study of LY3127804 in Participants With COVID-19
A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
A Study of U-500 Insulin (Humulin LY041001) in Participants With Type 2 Diabetes